Nealink received approval from an independent review board to begin recruiting for its first human trial of a brain implant aimed at people with paralysis from cervical spinal cord injuries or ALS. The trial is expected to last about six years, and Neuralink had initially sought to implant the device in ten patients before negotiating a potentially lower number with the FDA.
One outlet so far Only Maldives Republic has reported this among the sources we monitor. A gap in what we monitor, not proof that others did not report it.
Nothing to compare yet. If another monitored source reports it, its headline appears beside this one.
Neuralink, has obtained approval from an independent review board to initiate recruitment for the first human trial of its brain implant designed to aid paralysis patients.
Word for word from the report in Maldives Republic. Open the report
In May, Neuralink announced FDA clearance for its first-in-human clinical trial, although the startup had been under federal scrutiny for its handling of animal testing.
Word for word from the report in Maldives Republic. Open the report